This company listing is no longer active
600466 Stock Overview
Sichuan Languang Development Co., Ltd. engages in real estate development business in China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Sichuan Languang Development Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥0.40 |
52 Week High | CN¥1.89 |
52 Week Low | CN¥0.40 |
Beta | 0.81 |
1 Month Change | -4.76% |
3 Month Change | -62.96% |
1 Year Change | -76.33% |
3 Year Change | -92.26% |
5 Year Change | -94.14% |
Change since IPO | -87.89% |
Recent News & Updates
Recent updates
Shareholder Returns
600466 | CN Real Estate | CN Market | |
---|---|---|---|
7D | 0% | -2.4% | -0.4% |
1Y | -76.3% | -31.4% | -16.2% |
Return vs Industry: 600466 underperformed the CN Real Estate industry which returned -10.8% over the past year.
Return vs Market: 600466 underperformed the CN Market which returned -5.1% over the past year.
Price Volatility
600466 volatility | |
---|---|
600466 Average Weekly Movement | 8.7% |
Real Estate Industry Average Movement | 7.8% |
Market Average Movement | 8.9% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 600466's share price has been volatile over the past 3 months.
Volatility Over Time: 600466's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 1,622 | Wuzheng Yang | www.brc.com.cn |
Sichuan Languang Development Co., Ltd. engages in real estate development business in China. It is also involved in the modern service, biomedicine, and 3D bioprinting business. The company was formerly known as Sichuan Di Kang Technology Pharmaceutical Co., Ltd.
Sichuan Languang Development Co., Ltd. Fundamentals Summary
600466 fundamental statistics | |
---|---|
Market cap | CN¥1.21b |
Earnings (TTM) | -CN¥25.32b |
Revenue (TTM) | CN¥16.73b |
0.1x
P/S Ratio0.0x
P/E RatioIs 600466 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600466 income statement (TTM) | |
---|---|
Revenue | CN¥16.73b |
Cost of Revenue | CN¥31.68b |
Gross Profit | -CN¥14.95b |
Other Expenses | CN¥10.37b |
Earnings | -CN¥25.32b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -8.34 |
Gross Margin | -89.40% |
Net Profit Margin | -151.41% |
Debt/Equity Ratio | -220.1% |
How did 600466 perform over the long term?
See historical performance and comparison